Top compounds associated with response to ANKRD62


Feature Type Standardized
Nominal ANOVA
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.085 0.08
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.08
mRNA tamatinib CTRPv2 pan-cancer AAC 0.064 0.08
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.062 0.08
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.065 0.08
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.073 0.09
mRNA GSK1059615 CTRPv2 pan-cancer AAC 0.076 0.09
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.053 0.09
mRNA birinapant CTRPv2 pan-cancer AAC -0.062 0.1
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.053 0.1
Download CSV